norgestimate has been researched along with norgestrel in 172 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (8.14) | 18.7374 |
| 1990's | 75 (43.60) | 18.2507 |
| 2000's | 63 (36.63) | 29.6817 |
| 2010's | 16 (9.30) | 24.3611 |
| 2020's | 4 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lawson, JS; Osterman, JJ; Pasquale, SA; Yuliano, SE | 1 |
| Gonzales-Ansorena, R; Rubio-Lotvin, B | 1 |
| Abrams, LS; McGuire, JL; Patrick, JE; Weintraub, HS | 1 |
| Anderson, FD | 2 |
| Andolsek, KM | 1 |
| Dain, MP; Gauthier, A; Upmalis, D | 1 |
| Dain, MP; Janaud, A; Rouffy, J; Upmalis, D | 1 |
| Burkman, RT; Kafrissen, ME; Olson, W; Osterman, J | 1 |
| Chapdelaine, A; London, RS; Olson, W; Smith, J; Upmalis, D | 1 |
| Gillmer, MD | 1 |
| Corson, SL; Kafrissen, ME | 1 |
| Baz, CR | 1 |
| Van Lierde, M | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 2 |
| Kafrissen, ME | 1 |
| London, RS | 1 |
| Grunwald, K; Rabe, T; Runnebaum, B | 1 |
| Bringer, J | 1 |
| Huber, J | 1 |
| Rebar, RW; Zeserson, K | 1 |
| Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
| Back, DJ; Rudland, PS; Wild, MJ | 2 |
| Husslein, P; Kunze, M; Schoberberger, R | 1 |
| Back, DJ; Madden, S | 1 |
| Danforth, DR; Hahn, D; Hodgen, GD; Hsiu, JG; McGuire, JL; Roh, SI; Williams, RF | 1 |
| Flor, S; Hahn, DW; Kafrissen, ME; McGuire, JL; Phillips, A; Tolman, EL | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Chapdelaine, A; Derman, RJ; Desmarais, JL | 1 |
| Back, DJ; Madden, S; Orme, ML | 1 |
| Phillips, A | 1 |
| Corson, SL | 3 |
| Becker, H | 1 |
| Demarest, K; Hahn, DW; McGuire, JL; Phillips, A; Wong, F | 1 |
| Chez, RA | 2 |
| Brilli, G; Cleva, M; De Ramundo, BM; Genazzani, AR; Mercuri, N; Petraglia, F; Volpe, A | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Buchi, K; Elstein, M; Eyong, E | 1 |
| Lane, PA; Mayberry, DO; Young, RW | 1 |
| Hull, ME; Moghissi, KS | 1 |
| Hahn, DW; Hetyei, NS; Killinger, J; McGuire, JL; Phillips, A | 1 |
| Alton, KB; Hetyei, NS; Patrick, JE; Shaw, C | 1 |
| Borin, K; Moghissi, KS; Mohsenian, M | 1 |
| Casper, RF; Chachra, D; Grynpas, MD; Kasra, M; MacLusky, NJ; Vanin, CM | 1 |
| Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R | 1 |
| Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Fritzemeier, KH; Hegele-Hartung, C; Krattenmacher, R; Kuhnz, W | 1 |
| Sobel, NB | 1 |
| Affinito, P; Di Carlo, C; Farace, MJ; Monterubbianesi, M; Nappi, C; Petrillo, G; Primizia, M; Regine, V | 1 |
| Blode, H; Kuhnz, W; Mahler, M | 1 |
| Beier, S; Kuhnz, W | 1 |
| Andolsek, KM; Burkman, RT; Kafrissen, ME; Olson, W; Osterman, J | 1 |
| Anderson, FD; Gillmer, MD | 1 |
| Elger, W; Hoffmann, G; Juchem, M; Möbus, V; Pollow, K | 1 |
| DeCherney, A; Speroff, L | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
| Teichmann, A | 1 |
| Donnelly, RJ | 1 |
| Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY | 1 |
| Creinin, MD | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Lox, CD | 2 |
| Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W | 1 |
| Jones, TM; Jorizzo, JL; Kafrissen, ME; Lippman, JS; Olson, WH; Redmond, GP | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 2 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Cao, S; Wang, Z | 1 |
| Stanczyk, FZ | 1 |
| Henderson, TA; Lebwohl, M; Lucky, AW; Olson, WH; Robisch, DM; Swinyer, LJ | 1 |
| Gross, W; Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Redmond, GP | 1 |
| Charkoudian, N; Johnson, JM | 1 |
| Godwin, A; Lippman, J; Massaro, J; Siu, C; Sulak, P | 1 |
| Chroust, K; Cibula, D; Horejsí, J; Paseka, J; Rotta, L; Unzeitig, V | 2 |
| Duda, M; Edom, RW; Huang, M; Juzwin, S; Tegegne, G; Tischio, JP; Wong, FA | 1 |
| Caubel, P; Lane, R; Lobo, RA; Zacur, HZ | 1 |
| Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Caubel, P; Lim, P; Ylikorkala, O | 1 |
| Bourg, D; Curtin, CR; Gisclon, LG; Larson, KL; Morrison, DN; Natarajan, J; Wong, FA | 1 |
| Kowald, A; Ortmann, J; Rabe, T; Rehberger-Schneider, S | 1 |
| Davis, A; Godwin, A; Kafrissen, M; Lippman, J; Olson, W | 1 |
| Rozenberg, S | 1 |
| Caubel, P; Lim, PC; Rozenberg, S | 1 |
| Chroust, K; Cibula, D; Paseka, J; Unzeitig, V | 1 |
| Henzl, MR | 1 |
| Mattox, JH; Shulman, LP | 1 |
| Bancroft, J; Bass, JL; Graham, CA; Sanders, SA | 1 |
| Gergely, A; Horváth, P; Mahó, S; Mátyus, P; Szász, G; Szentesi, A | 1 |
| Cibula, D; Fanta, M; Hill, M; Sindelka, G; Skrha, J; Zivny, J | 1 |
| Curran, MP; Wagstaff, AJ | 2 |
| Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Zieman, M | 1 |
| Abrams, LS; Natarajan, J; Skee, D; Wong, FA | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Caubel, P; Lane, R; Wahlström, T; Ylikorkala, O | 1 |
| Creinin, MD; Eder, SE; Godwin, AJ; Lippman, JS; Olson, W | 1 |
| Taneepanichskul, S; Tantbirojn, P | 1 |
| Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
| Hönigsmann, H; Sator, PG; Schmidt, JB | 1 |
| Eterović, D; Strinić, T | 1 |
| Fisher, A; Friedman, A; Kafrissen, M; LaGuardia, KD; Shangold, G | 1 |
| Friedman, AJ; Grinspoon, SK; Lippman, J; Miller, KK; Olson, WH; Warren, MP | 1 |
| Kaunitz, AM | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T; Zhong, G | 1 |
| Arrenbrecht, S; Caubel, P; Felsenberg, D; Garnero, P | 1 |
| del Marmol, V; Gertsen, K; Teichmann, A | 1 |
| Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD | 1 |
| Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
| Jain, JK; Stanczyk, FZ; White, T | 1 |
| Becker, M; Haefeli, WE; Lindenmaier, H; Weiss, J | 1 |
| Friedman, AJ; Grinspoon, SK; Miller, KK; Olson, WH; Warren, MP | 1 |
| O'Connell, KJ; Osborne, LM; Westhoff, C | 1 |
| Jick, H; Jick, SS; Kaye, JA; Russmann, S | 2 |
| Birtch, RL; Olatunbosun, OA; Pierson, RA | 1 |
| Friedman, AJ; Langer, RD | 1 |
| Jick, H; Jick, SS | 2 |
| Brenner, P | 1 |
| Burrows, M; Peters, C | 1 |
| Cole, JA; Doherty, M; Norman, H; Walker, AM | 1 |
| Bettenhausen, DK; Connolly, M; Forbes, WP; Pentikis, H; Trapnell, CB | 1 |
| Devineni, D; Janssens, L; LaGuardia, KD; Leung, AT; Massarella, J; Skee, D; Vaccaro, N | 1 |
| Bacquet, A; Balaguer, P; Paris, F; Rabeolina, F; Sultan, C | 1 |
| Jick, H; Jick, S; Kaye, JA; Li, L | 1 |
| Bancroft, J; Doll, HA; Graham, CA; Greco, T; Tanner, A | 1 |
| Tan, JK | 1 |
| Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
| De Souza, MJ; VanHeest, JL; Vescovi, JD | 1 |
| Badger, GJ; Cushman, M; Johnson, JV; Lowell, J; Rosing, J; Tchaikovski, S | 1 |
| Barnowski, C; Hampton, RM; Wan, GJ; Zhang, HF | 1 |
| Banárová, A; Koller, T; Kollerová, J; Ondrias, F; Payer, J | 1 |
| Ferriani, RA; Mendes Laureano, J; Romao, GS; Sá, MF | 1 |
| Buono, MJ; Martin, JG | 1 |
| Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ | 1 |
| Anderson, MS; Bieberdorf, FA; Hanley, WD; Iwamoto, M; Jin, B; Kost, JT; Moreau, AR; Stone, JA; Wagner, JA; Wenning, LA | 1 |
| Bertz, R; Eley, T; Garner, D; Krantz, K; Nettles, R; Persson, A; Sevinsky, H; Yones, C; Zhang, J | 1 |
| Bertz, R; Chung, E; Eley, T; Mahnke, L; Persson, A; Xu, X; Yones, C; Zhang, J | 1 |
| Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS | 1 |
| Crause, P; Dittrich, W; Kleemann, HW; Licher, T; Löhn, M; Miehe, S; Rütten, H; Schmidt, T; Strübing, C | 1 |
| Lidegaard, O; Løkkegaard, E; Nielsen, LH; Skovlund, CW | 1 |
| Hall, KS; Trussell, J | 1 |
| Nyberg, S | 1 |
| Angsuwathana, S; Chaovisitsaree, S; Jaisamrarn, U; Nerapusee, O | 1 |
| Bain, PA; Iguchi, T; Kumar, A; Ogino, Y | 1 |
| Balaguer, P; Gaspari, L; Paris, F; Rimbault, F; Sultan, C | 1 |
| Backos, A; Bartlett, H; Callaghan, JH; Callaghan, MU; Chitlur, M; Marshall, S; Rajpurkar, M; Sawni, A; Zia, A | 1 |
| Adeniji, AA; Cheang, KI; Essah, PA; Nestler, JE | 1 |
| Chen, M; Huang, MQ; Kang, L; Lin, ZJ; Skee, D; Verhaeghe, T; Wang, W; Weng, N | 1 |
| Fakayode, SO; Hordge, LN; Jones, DD; McDaniel, KL | 1 |
| Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK | 1 |
| Chang, W; Dragoo, JL; Hsue, L; Konopka, JA; Thio, T | 1 |
| Del Savio, MC; Facchinetti, F; Grandi, G | 1 |
| Chiu, YL; Feldman, RA; Klein, CE; Ng, J | 1 |
| Facchinetti, F; Grandi, G; Guariglia, G | 1 |
36 review(s) available for norgestimate and norgestrel
| Article | Year |
|---|---|
Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
Topics: Acne Vulgaris; Animals; Body Weight; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Meta-Analysis as Topic; Norgestrel; Prolactin; Receptors, Androgen; Receptors, Progesterone; Sex Hormone-Binding Globulin | 1992 |
Norgestimate: a preclinical profile.
Topics: Androgens; Animals; Endometrium; Estrogen Antagonists; Estrogens; Female; Humans; Norgestrel; Ovulation; Receptors, Progesterone | 1992 |
The European experience: an overview.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Europe; Female; Humans; Norgestrel; Progesterone Congeners | 1992 |
Comparative review of third-generation progestins.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norgestrel; Norpregnenes | 1992 |
Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
Topics: Androgens; Animals; Drug Evaluation, Preclinical; Endometrium; Estrogen Antagonists; Estrogens; Female; Humans; Norgestrel; Ovulation; Progestins; Rabbits; Rats; Receptors, Progesterone | 1992 |
The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners | 1992 |
Norgestimate: a clinical overview of a new progestin.
Topics: Female; Humans; Metabolism; Norgestrel | 1992 |
Characteristics of the new progestogens in combination oral contraceptives.
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1991 |
Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites.
Topics: Animals; Biotransformation; Contraceptives, Oral; Drug Combinations; Female; Humans; Levonorgestrel; Molecular Structure; Norgestrel; Oximes | 1990 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Gastrointestinal metabolism of contraceptive steroids.
Topics: Aged; Biological Availability; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Norgestrel; Norpregnenes; Sulfates | 1990 |
The selectivity of a new progestin.
Topics: Animals; Female; Male; Norgestrel; Ovulation; Progesterone Congeners; Prostate; Rabbits; Rats; Receptors, Androgen | 1990 |
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
Topics: Carbohydrate Metabolism; Desogestrel; Drug Evaluation; Female; Humans; Lipid Metabolism; Menstrual Cycle; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners; Proteins | 1989 |
Metabolic aspects of the new low-dose oral contraceptives.
Topics: Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Proteins | 1989 |
[New progestational hormones].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners | 1988 |
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Female; Humans; Lipids; Menstruation Disturbances; Norgestrel | 1994 |
Norgestimate: overview of a monophasic formulation.
Topics: Animals; Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipid Metabolism; Norgestrel; Ovulation; Progestins; Rabbits; Receptors, Androgen; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.
Topics: Androgens; Blood Coagulation; Blood Glucose; Contraceptives, Oral; Desogestrel; Female; Humans; Insulin; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1993 |
Norgestimate.
Topics: Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Contraceptives, Oral; Endometrium; Female; Humans; Norgestrel; Progestins | 1995 |
[Advances in the research on new generation of oral contraceptive agents].
Topics: Contraceptives, Oral, Synthetic; Humans; Norgestrel; Norpregnenes | 1996 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation.
Topics: Bias; Blood Coagulation; Contraceptives, Oral, Synthetic; Drug Resistance; Factor V; Female; Humans; Norgestrel; Progesterone Congeners; Protein C; Risk Factors; Thrombophlebitis | 1997 |
Effectiveness of oral contraceptives in the treatment of acne.
Topics: Acne Vulgaris; Adolescent; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Male; Norgestrel; Randomized Controlled Trials as Topic | 1998 |
Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
Topics: Animals; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hormone Replacement Therapy; Humans; Menopause; Norgestrel; Progestins; Risk Factors | 2001 |
Norgestimate. From the laboratory to three clinical indications.
Topics: Contraceptives, Oral, Sequential; Female; Hormone Replacement Therapy; Humans; Hyperandrogenism; Norgestrel | 2001 |
Combined oral hormone replacement therapy formulations.
Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Norgestrel; Treatment Refusal | 2001 |
Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.
Topics: Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norgestrel | 2001 |
Pharmacokinetic overview of Ortho Evra/Evra.
Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes | 2002 |
Enhancing oral contraceptive success: the potential of new formulations.
Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel | 2004 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.
Topics: Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Postmenopause | 2002 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult | 2017 |
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.
Topics: Animals; Contraceptive Agents, Hormonal; Female; Humans; Levonorgestrel; Norgestrel; Risk; Venous Thromboembolism | 2021 |
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review.
Topics: Acne Vulgaris; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norgestrel | 2023 |
64 trial(s) available for norgestimate and norgestrel
| Article | Year |
|---|---|
Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Evaluation; Ethinyl Estradiol; Female; Gastrointestinal Diseases; Humans; Norgestrel; Pregnancy; Random Allocation; Uterine Hemorrhage | 1979 |
Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Patient Compliance; Premenstrual Syndrome | 1992 |
Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norgestrel; Patient Compliance; Pregnancy | 1992 |
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel | 1992 |
Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1992 |
A postpartum clinical trial with a new progestin, norgestimate.
Topics: Contraceptives, Oral, Hormonal; Female; Humans; Menstrual Cycle; Norgestrel; Postpartum Period; Time Factors | 1992 |
The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Triglycerides | 1992 |
Clinical experience with a new norgestimate-containing oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel | 1991 |
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
[Clinical evidence of the minimal androgenic activity of norgestimate].
Topics: Acne Vulgaris; Adult; Androgens; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Multicenter Studies as Topic; Norgestrel; Sex Hormone-Binding Globulin; Weight Gain | 1990 |
Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials.
Topics: Adolescent; Adult; Cervix Mucus; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Ovulation; Sex Hormone-Binding Globulin; United States | 1990 |
Supportive European data on a new oral contraceptive containing norgestimate.
Topics: Adolescent; Adult; Blood Coagulation; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Evaluation; Endometrium; Europe; Female; Humans; Lipid Metabolism; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Sex Hormone-Binding Globulin | 1990 |
Effects of 180 micrograms and 250 micrograms norgestimate on pituitary-ovarian function and cervical mucus.
Topics: Adult; Cervix Mucus; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norgestrel; Ovary; Ovulation; Pituitary Gland | 1988 |
Ovarian function during low-dose oral contraceptive use.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography | 1995 |
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Norgestrel; Norpregnenes | 1993 |
Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
Topics: Adolescent; Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1994 |
Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Triglycerides | 1993 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
Biochemical effects in women following one year's exposure to a new triphasic contraceptive--I. chemistry profiles.
Topics: Adult; Blood Cell Count; Blood Chemical Analysis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Hematologic Tests; Humans; Norgestrel; Progestins; Women's Health | 1996 |
Biochemical effects in women following one year's exposure to a new triphasic contraceptive--II. coagulation profiles.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Norgestrel; Progestins; Protein C; Women's Health | 1996 |
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin | 1996 |
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Prospective Studies | 1997 |
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Middle Aged; Nausea; Norgestrel; Patient Participation; Prospective Studies; Respiratory Tract Infections; Treatment Outcome | 1997 |
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Reference Values; Triglycerides | 1998 |
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Topics: Androgens; Contraception; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Norgestrel; Patient Satisfaction | 1999 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
[Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women].
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norgestrel; Patient Satisfaction; Pregnancy; Prospective Studies | 1999 |
A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoprotein(a); Lipoproteins; Middle Aged; Norgestrel; Triglycerides | 2000 |
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides | 1999 |
Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Topics: Administration, Oral; Cholesterol; Cholesterol, HDL; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Triglycerides | 2000 |
Lack of effect of a high-fat meal on the bioavailability of 17 beta-estradiol/norgestimate in healthy postmenopausal women.
Topics: Biological Availability; Contraceptives, Oral, Synthetic; Cross-Over Studies; Dietary Fats; Estradiol; Female; Food-Drug Interactions; Humans; Middle Aged; Norgestrel; Postmenopause; Women's Health | 2000 |
Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Middle Aged; Norgestrel; Treatment Outcome | 2000 |
Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
Topics: Adult; Aged; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progestins; Uterine Hemorrhage; Vasomotor System | 2001 |
[Liver function tests during administration of triphasic contraceptives containing Norgestimate].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Liver Function Tests; Norgestrel; Prospective Studies | 2000 |
A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation.
Topics: Adult; Affect; Analysis of Variance; Attitude; Contraception; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Logistic Models; Marriage; Norgestrel; Prospective Studies; Sexuality; Surveys and Questionnaires; Time Factors | 2001 |
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
Topics: Adult; Aged; Biopsy; Cholesterol; Drug Administration Schedule; Endometrium; Estradiol; Female; Hormone Replacement Therapy; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norgestrel; Uterine Hemorrhage | 2002 |
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovarian Follicle; Patient Compliance; Progesterone | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Ovulation; Pregnancy; Progesterone; Racial Groups; Uterine Hemorrhage | 2003 |
Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Cognition; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypothalamic Diseases; Norgestrel | 2003 |
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Topics: Aged; Body Mass Index; Bone and Bones; Bone Density; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol; Female; Humans; Middle Aged; Norgestrel; Osteoporosis, Postmenopausal; Patient Dropouts; Patient Selection; Treatment Outcome | 2004 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2005 |
Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study.
Topics: Absorptiometry, Photon; Adolescent; Adult; Amenorrhea; Biomarkers; Bone Density; Bone Diseases, Metabolic; Contraceptives, Oral, Synthetic; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Hypothalamic Diseases; Lumbar Vertebrae; Norgestrel | 2005 |
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain | 2005 |
Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Ovarian Follicle; Time Factors; Ultrasonography | 2006 |
Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Middle Aged; Norgestrel; Postmenopause; Treatment Outcome; Triglycerides | 2006 |
Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Ethinyl Estradiol; Exercise; Female; Humans; Leg; Levonorgestrel; Muscle Strength; Norgestrel; Progesterone Congeners; Progestins; Sports | 2006 |
Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Rifamycins; Rifaximin; Therapeutic Equivalency | 2007 |
Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
Topics: Abdomen; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Buttocks; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Female; Half-Life; Humans; Middle Aged; Norgestrel; Oximes | 2007 |
The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
Topics: Adolescent; Adult; Affect; Androgens; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Humans; Norgestrel; Premenstrual Syndrome; Sex Hormone-Binding Globulin; Sexual Behavior; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2007 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
Topics: Adult; Amenorrhea; Biomarkers; Bone and Bones; Bone Resorption; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Energy Intake; Energy Metabolism; Ethinyl Estradiol; Exercise; Female; Humans; Hypothalamic Diseases; Norgestrel; Peptide Fragments; Procollagen; Prospective Studies | 2008 |
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Antithrombins; Blood Coagulation; Blood Proteins; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norgestrel; Oximes; Protein S; Risk Factors; Thrombosis; von Willebrand Factor | 2008 |
Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norgestrel; Retrospective Studies; Treatment Outcome | 2008 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult | 2009 |
Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Drug Interactions; Estradiol; Estrogens; Female; Humans; Middle Aged; Norgestrel; Peptide Fragments; Pyrrolidinones; Raltegravir Potassium; Statistics as Topic; Young Adult | 2011 |
A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norgestrel; Treatment Outcome; Young Adult | 2014 |
72 other study(ies) available for norgestimate and norgestrel
| Article | Year |
|---|---|
Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstruation; Norgestrel | 1978 |
Disposition of norgestimate in the presence and absence of ethinyl estradiol after oral administration to humans.
Topics: Administration, Oral; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Intestinal Absorption; Kinetics; Norgestrel | 1978 |
Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate.
Topics: Adolescent; Adult; Blood Glucose; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Lipids; Norgestrel | 1992 |
Cilest (norgestimate/EE): some clinical observations.
Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Female; Glucose; Humans; Norgestrel | 1992 |
A norgestimate-containing oral contraceptive: review of clinical studies.
Topics: Blood Coagulation; Body Weight; Carbohydrate Metabolism; Contraceptives, Oral; Endocrine Glands; Female; Humans; Lipids; Lipoproteins; Menstrual Cycle; Norgestrel | 1992 |
Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in culture.
Topics: Breast; Breast Neoplasms; Cell Line; Contraceptives, Oral; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Norgestrel; Radioisotope Dilution Technique; Tritium; Tumor Cells, Cultured | 1991 |
[Acceptance and subjective well-being with a norgestimate combination pill].
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Female; Humans; Menstrual Cycle; Middle Aged; Norgestrel; Patient Acceptance of Health Care; Quality of Life | 1991 |
Metabolism of norgestimate by human gastrointestinal mucosa and liver microsomes in vitro.
Topics: Chromatography, High Pressure Liquid; Gastric Mucosa; Humans; Mass Spectrometry; Microsomes, Liver; Molecular Structure; Norgestrel | 1991 |
Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposure.
Topics: Animals; Drug Therapy, Combination; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Macaca fascicularis; Norgestrel; Ovary; Progesterone; Progestins | 1990 |
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
Topics: Animals; Dihydrotestosterone; In Vitro Techniques; Male; Norgestrel; Norpregnenes; Progesterone; Progestins; Prostate; Rabbits; Rats; Receptors, Androgen; Receptors, Progesterone | 1990 |
Norgestimate increases pituitary and hypothalamic concentrations of immunoreactive beta-endorphin.
Topics: Animals; beta-Endorphin; Estradiol; Female; Hypothalamus; Norgestrel; Pituitary Gland; Radioimmunoassay; Rats; Rats, Inbred Strains | 1989 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Determination of norgestimate and ethinyl estradiol in tablets by high-performance liquid chromatography.
Topics: Drug Stability; Ethinyl Estradiol; Norgestrel; Tablets | 1987 |
Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucus.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norgestrel | 1986 |
The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterus.
Topics: Animals; Binding, Competitive; Chromatography, High Pressure Liquid; Endometrium; Female; Levonorgestrel; Norgestrel; Progesterone; Rabbits; Receptors, Progesterone; Uterus | 1985 |
Biotransformation of norgestimate in women.
Topics: Biotransformation; Carbon Radioisotopes; Feces; Female; Humans; Norgestrel | 1984 |
Effects of norgestimate in combination with ethinyl estradiol on cervical mucus.
Topics: Adolescent; Adult; Body Temperature; Cervix Mucus; Ethinyl Estradiol; Female; Humans; Male; Menstruation; Norgestrel; Spermatozoa | 1981 |
Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate.
Topics: Absorptiometry, Photon; Animals; Bone Density; Dihydrotestosterone; Drug Implants; Estradiol; Female; Lumbar Vertebrae; Norethindrone; Norgestrel; Ovariectomy; Rats; Rats, Sprague-Dawley; Silicone Elastomers | 1995 |
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.
Topics: Animals; Drug Combinations; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1995 |
Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat.
Topics: Androgens; Animals; Female; Kinetics; Levonorgestrel; Male; Norgestrel; Orchiectomy; Organ Size; Pregnancy; Pregnancy Maintenance; Progesterone Congeners; Prostate; Rats; Seminal Vesicles | 1994 |
Receptor binding of norgestimate--a new orally active synthetic progestational compound.
Topics: Animals; Binding, Competitive; Carrier Proteins; Female; Humans; In Vitro Techniques; Kidney; Liver; Male; Norgestrel; Pregnancy; Prostate; Rats; Rats, Wistar; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Receptors, Steroid; Sex Hormone-Binding Globulin; Uterus | 1993 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Third generation oral contraceptives. Study's results do not apply to norgestimate.
Topics: Contraceptives, Oral, Synthetic; Female; Humans; Norgestrel; Thromboembolism | 1996 |
Safety of combined oral contraceptive pills.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism | 1996 |
Laboratory criteria for menopause in women using oral contraceptives.
Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors | 1996 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
Altered reflex control of cutaneous circulation by female sex steroids is independent of prostaglandins.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Combinations; Estradiol Congeners; Female; Heart Rate; Hot Temperature; Humans; Ibuprofen; Mestranol; Norethindrone; Norgestrel; Prostaglandins; Reflex; Skin; Stress, Physiological; Sweating; Vasodilation | 1999 |
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Stability; Female; Humans; Levonorgestrel; Mass Spectrometry; Molecular Structure; Norgestrel; Oximes; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
[Prediction of the effect of a triphasic contraceptive agent with norgestimate on acne].
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Humans; Norgestrel; Prospective Studies; Skin | 2000 |
Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Contraceptives, Oral; Dose-Response Relationship, Drug; Female; Humans; Hyperandrogenism; Nandrolone; Norgestrel; Progestins; Receptors, Androgen; Skin | 2000 |
Determination of circular dichroism and ultraviolet spectral parameters of norgestimate- and other Delta(4)-3-ketosteroid oxime isomers via normal phase HPLC method.
Topics: Chromatography, High Pressure Liquid; Circular Dichroism; Isomerism; Ketosteroids; Magnetic Resonance Spectroscopy; Norgestrel; Oximes; Spectrophotometry, Ultraviolet; Stereoisomerism | 2001 |
Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.
Topics: Adult; Androstenedione; Blood Glucose; Body Constitution; Body Mass Index; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Female; Glucose Clamp Technique; Humans; Insulin; Luteinizing Hormone; Metabolic Clearance Rate; Norgestrel; Polycystic Ovary Syndrome; Testosterone | 2002 |
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins | 2002 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris. A pilot study.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Pilot Projects; Prospective Studies; Treatment Outcome | 2003 |
Less estrogen in new oral contraceptive.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel | 2003 |
Oral contraceptives improve lung mechanics.
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Forced Expiratory Volume; Humans; Norgestrel; Respiratory Mechanics | 2003 |
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
Topics: 17-alpha-Hydroxyprogesterone; Cell Line, Tumor; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Ethisterone; Female; Humans; Matrix Metalloproteinase 2; Norgestrel; Oximes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2004 |
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |
Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2).
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Line; Contraceptives, Oral, Synthetic; Dogs; Dose-Response Relationship, Drug; Fluoresceins; Humans; Microscopy, Confocal; Norgestrel; Progesterone; Progestins; Propionates; Quinolines; Swine; Time Factors; Transfection | 2005 |
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Topics: Administration, Cutaneous; Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Factors; Thromboembolism | 2006 |
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism | 2006 |
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Norgestrel; Risk; Sinus Thrombosis, Intracranial | 2006 |
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Norgestrel; Pregnancy; Risk; Thromboembolism | 2006 |
The contraceptive patch in relation to ischemic stroke and acute myocardial infarction.
Topics: Administration, Topical; Adolescent; Adult; Brain Ischemia; Contraceptive Agents; Contraceptives, Oral; Female; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Retrospective Studies; Stroke | 2007 |
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis | 2007 |
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levonorgestrel; Norgestrel; Oximes; Protein Binding; Receptors, Androgen; Time Factors; Transfection | 2007 |
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Databases, Factual; Ethinyl Estradiol; Female; Humans; Managed Care Programs; Norgestrel; Risk Factors; Thromboembolism; United States | 2007 |
[Acute cholestasis following treatment with nimesulide and oral contraception: case report and review].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestasis; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Interactions; Ethinyl Estradiol; Female; Humans; Liver; Norgestrel; Sulfonamides | 2008 |
Variations of jitter and shimmer among women in menacme and postmenopausal women.
Topics: Adult; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norgestrel; Phonetics; Postmenopause; Speech; Speech Acoustics; Young Adult | 2009 |
The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Benzoxazines; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclopropanes; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Reverse Transcriptase Inhibitors; Young Adult | 2011 |
The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Oligopeptides; Pyridines; Ritonavir; Women's Health; Young Adult | 2011 |
Adolescents' experiences using the contraceptive patch versus pills.
Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult | 2011 |
Inhibition of diacylglycerol-sensitive TRPC channels by synthetic and natural steroids.
Topics: Animals; Aorta, Thoracic; Calcium; Diglycerides; Humans; Male; Myocytes, Smooth Muscle; Norgestrel; Progesterone; Rats; Rats, Wistar; Receptors, Vasopressin; Steroids; TRPC Cation Channels; TRPC6 Cation Channel; Vasopressins | 2012 |
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Topics: Adolescent; Adult; Anticoagulants; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Denmark; Drug Implants; Epidemiologic Methods; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Transdermal Patch; Venous Thrombosis; Young Adult | 2012 |
Types of combined oral contraceptives used by US women.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Estradiol Congeners; Family Characteristics; Female; Health Surveys; Humans; Norethindrone; Norgestrel; Progesterone Congeners; United States; Young Adult | 2012 |
Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol.
Topics: Activities of Daily Living; Adult; Breast; Contraceptives, Oral, Combined; Diagnostic and Statistical Manual of Mental Disorders; Edema; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Irritable Mood; Luteal Phase; Norgestrel; Patient Dropouts; Premenstrual Syndrome; Prospective Studies; Psychiatric Status Rating Scales; Secondary Prevention; Severity of Illness Index; Sweden; Young Adult | 2013 |
Nortestosterone-derived synthetic progestogens do not activate the progestogen receptor of Murray-Darling rainbowfish (Melanotaenia fluviatilis) but are potent agonists of androgen receptors alpha and beta.
Topics: Androgens; Androstenes; Animals; Female; Fishes; Male; Nandrolone; Norgestrel; Poecilia; Progesterone Congeners; Progestins; Receptors, Androgen; Receptors, Progesterone; Smegmamorpha; Water Pollutants, Chemical | 2015 |
Molecular action of norgestimate: new developments.
Topics: Cell Line; Contraceptives, Oral, Synthetic; Estrogen Receptor alpha; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Progestins; Receptors, Glucocorticoid | 2015 |
Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms.
Topics: Adolescent; Blood Coagulation; Blood Coagulation Tests; Contraceptives, Oral; Estrogen Receptor alpha; Ethinyl Estradiol; Factor V; Factor VIII; Female; Gene Expression; Heterozygote; Homozygote; Humans; Norgestrel; Polymorphism, Single Nucleotide; Protein S; Thrombin; Thrombomodulin; Thrombophilia; von Willebrand Factor; Young Adult | 2015 |
Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
Topics: Adult; Blood Glucose; Carbohydrates; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Lipid Metabolism; Lipids; Norgestrel; Polycystic Ovary Syndrome | 2016 |
UPLC-MS/MS assay for the simultaneous determination of ethinyl estradiol, norgestimate and 17-Desacetyl norgestimate at low pg/mL in human plasma.
Topics: Chromatography, Liquid; Ethinyl Estradiol; Humans; Norgestrel; Quality Control; Reference Standards; Tandem Mass Spectrometry | 2016 |
Simultaneous determination of estrogens (ethinylestradiol and norgestimate) concentrations in human and bovine serum albumin by use of fluorescence spectroscopy and multivariate regression analysis.
Topics: Animals; Cattle; Estrogens; Ethinyl Estradiol; Humans; Least-Squares Analysis; Multivariate Analysis; Norgestrel; Serum Albumin, Bovine; Spectrometry, Fluorescence; Time Factors | 2016 |
The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength.
Topics: Androstenes; Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Norethindrone; Norgestrel; Progestins; Rats; Rats, Sprague-Dawley | 2020 |
Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women.
Topics: Female; Follicle Stimulating Hormone; Humans; Hydrocarbons, Fluorinated; Luteinizing Hormone; Norethindrone; Norgestrel; Pyrimidines | 2021 |